Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

British Journal of Cancer 116, 318 (31 January 2017). doi:10.1038/bjc.2016.413

Authors: Federica Marmorino, Lisa Salvatore, Cecilia Barbara, Giacomo Allegrini, Lorenzo Antonuzzo, Gianluca Masi, Fotios Loupakis, Beatrice Borelli, Silvana Chiara, Maria Chiara Banzi, Emanuela Miraglio, Domenico Amoroso, Francesco Dargenio, Andrea Bonetti, Angelo Martignetti, Myriam Paris, Daniela Tomcikova, Luca Boni, Alfredo Falcone & Chiara Cremolini

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2j6sbN4
via IFTTT